SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HRC HEALTHSOUTH

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Curtis Brown who wrote (8)3/6/1999 9:57:00 AM
From: Fred Thornell  Read Replies (2) of 181
 

HealthSouth Corp Reiterated 'Strong Buy' ...
by: stock_craft 2890 of 2891
at Credit Suisse First.

Princeton, New Jersey, March 5 (Bloomberg Data) -- HealthSouth Corp. (HRC US) was reiterated ''strong buy'' by analyst Howard Capek at Credit Suisse First Boston Inc. The 12-month target price is $20.00 per share.

--------------------------------------------------------------------------------


"VIPER"
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext